Transcranial Electromagnetic Treatment Against Alzheimer's Disease

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

October 5, 2020

Study Completion Date

October 30, 2020

Conditions
Alzheimer DiseaseAlzheimer Disease, Late Onset
Interventions
DEVICE

MemorEM 1000

The MemorEM 1000 device is self-contained and has been designed for in-home daily electromagnetic treatment in the radiofrequency range, allowing for complete mobility and comfort in performing daily activities during treatment. The device has a custom control panel that is powered by a rechargeable battery. This control panel/battery box is worn on the upper arm and wired to specialized emitters in the head cap worn by the subject. The device provides global treatment to forebrain. For each of the 120 days of in-home treatment, a single 1-hour treatment will be administered by the subject's caregiver, who will position the device on the patient's head and monitor treatment.

Trial Locations (1)

33613

Byrd Alzheimer's Institute, University of South Florida, Tampa

Sponsors
All Listed Sponsors
lead

NeuroEM Therapeutics, Inc.

INDUSTRY

NCT03927040 - Transcranial Electromagnetic Treatment Against Alzheimer's Disease | Biotech Hunter | Biotech Hunter